Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Asunto principal
Intervalo de año de publicación
1.
Med Clin (Barc) ; 147(8): 348-351, 2016 Oct 21.
Artículo en Español | MEDLINE | ID: mdl-27575526

RESUMEN

BACKGROUND AND OBJECTIVE: Turner syndrome (TS) is characterized by short stature, gonadal dysgenesis, and total or partial loss of X chromosome. PATIENTS AND METHODS: A historical cohorts study of patients with TS≤18 years old followed up in public hospitals in Castilla y Leon was undertaken. RESULTS: Forty-two female patients were included (prenatal diagnosis 11.9%, neonatal diagnosis 14.3%) with current median age 11.9±4.2 years. Short stature was the reason for consultation in 87.1%. Total monosomy of X chromosome was present in 40.5%. The most frequently associated comorbidity was opthalmological (50%), with heart defects in 23.8%. Ninety-three percent were treated with growth hormone (GH), mean age at the beginning of treatment was 7.43±3.4 years and mean height standard deviation was -2.84±1.08. Final height was reached in 10 patients only (mean final height 151.47±6.09cm). Chronological age of puberty induction was 13.2±0.94 years (bone age 12.47±1.17 years). CONCLUSIONS: Short stature was an important clinical sign for the diagnosis of TS, accompanied in some cases by other findings, with good response to GH treatment.


Asunto(s)
Síndrome de Turner/diagnóstico , Adolescente , Niño , Preescolar , Femenino , Estudios de Seguimiento , Hormona del Crecimiento/uso terapéutico , Humanos , Lactante , Recién Nacido , Pronóstico , Estudios Retrospectivos , Síndrome de Turner/complicaciones , Síndrome de Turner/genética , Síndrome de Turner/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...